Fortis Healthcare Q1 Results FY2027: Revenue Rises 17% YoY, PAT Increases 2% to ₹273 Cr
Fortis Healthcare reported healthy revenue growth in Q1 FY27, supported by strong performance in its Healthcare and Diagnostics businesses, while profit remained stable despite lower operating margins.
Fortis Healthcare Q1 Results FY2027: Fortis Healthcare reported a healthy performance in Q1 FY27, supported by strong revenue growth across its Healthcare and Diagnostics businesses. The company delivered double-digit growth in revenue, while profitability remained stable despite a moderation in operating margins compared with the corresponding and previous quarters.
Fortis Healthcare Q1 Results FY2027: On 6 August 2026, Fortis Healthcare announced its financial results for the first quarter ended 30 June 2026. Revenue from Operations increased 17.46% YoY to ₹2,545 crore compared with ₹2,167 crore in Q1 FY26.
While Profit After Tax (PAT) increased 2.26% YoY to ₹273 crore compared with ₹267 crore in Q1 FY26. EBITDA Margin stood at 21.10% during the quarter.
Fortis Healthcare share price closed 0.54% lower on 6 August 2026. The stock has delivered 2% returns year-to-date and 7% returns over the one year from 6 August 2025 to 6 August 2026.
As of 6 Aug, 3:30 PM
READ THIS ALSO: Britannia Q1 Results FY2027
Fortis Healthcare Q1 FY27 Results Highlights
-
Revenue from Operations stood at ₹2,545 crore, registering a 17.46% YoY increase from ₹2,167 crore in Q1 FY26. Compared with ₹2,365 crore in Q4 FY26, revenue increased 7.63% QoQ.
-
Total Revenue stood at ₹2,560 crore, registering a 17.29% YoY increase from ₹2,182 crore in Q1 FY26. Compared with ₹2,369 crore in Q4 FY26, total revenue increased 8.04% QoQ.
-
EBITDA (Excluding Other Income) stood at ₹537 crore, compared with ₹491 crore in Q1 FY26, registering a 9.47% YoY increase. Compared with ₹532 crore in Q4 FY26, EBITDA increased 0.90% QoQ.
-
EBITDA Margin stood at 21.10%, compared with 22.65% in Q1 FY26 and 22.51% in Q4 FY26, declining by 1.54 percentage points YoY and 1.41 percentage points QoQ.
-
Profit After Tax (PAT) stood at ₹273 crore, compared with ₹267 crore in Q1 FY26, registering a 2.26% YoY increase. Compared with ₹271 crore in Q4 FY26, PAT increased 0.59% QoQ.
-
PAT Margin stood at 10.72%, compared with 12.31% in Q1 FY26 and 11.47% in Q4 FY26, declining by 1.59 percentage points YoY and 0.75 percentage points QoQ.
-
Profit After Tax attributable to owners of the company stood at ₹266 crore, compared with ₹260 crore in Q1 FY26, registering a 2.35% YoY increase.
-
EPS stood at ₹3.53, compared with ₹3.45 in Q1 FY26, registering a 2.32% YoY increase. Compared with ₹3.52 in Q4 FY26, EPS increased 0.28% QoQ.
|
Metric |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Revenue from Operations (₹ Cr) |
2,545 |
2,365 |
7.63% |
2,167 |
17.46% |
|
Total Revenue (₹ Cr) |
2,560 |
2,369 |
8.04% |
2,182 |
17.29% |
|
EBITDA (₹ Cr) |
537 |
532 |
0.90% |
491 |
9.47% |
|
EBITDA Margin |
21.10% |
22.51% |
-1.41 pp |
22.65% |
-1.54 pp |
|
PAT (₹ Cr) |
273 |
271 |
0.59% |
267 |
2.26% |
|
PAT Margin |
10.72% |
11.47% |
-0.75 pp |
12.31% |
-1.59 pp |
|
PAT (Owners) (₹ Cr) |
266 |
266 |
0.20% |
260 |
2.35% |
|
EPS (₹) |
3.53 |
3.52 |
0.28% |
3.45 |
2.32% |
Fortis Healthcare Q1 Segment-wise Performance
Fortis Healthcare reported healthy growth across both of its operating segments during Q1 FY27. The Healthcare business remained the largest contributor to revenue, while the Diagnostics segment also delivered double-digit year-on-year growth, supporting the company's overall revenue performance during the quarter.
|
Segment (₹ Cr) |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Healthcare |
2,186.67 |
2,023.00 |
8.08% |
1,837.83 |
18.98% |
|
Diagnostics |
406.54 |
387.00 |
4.98% |
368.82 |
10.23% |
|
Total Revenue from Operations |
2,545.03 |
2,364.67 |
7.63% |
2,166.72 |
17.46% |
Source: Company Filing
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.